Performance Marketing Designer, ByHeart

$160-170k

+ Equity & Discretionary performance based annual cash bonus

Adobe Creative Suite
After Effects
Premiere Pro
Mid and Senior level
New York

2+ days a week in office

ByHeart

Infant nutrition products

Be an early applicant

ByHeart

Infant nutrition products

101-200 employees

B2CFoodNutritionConsumer GoodsWellbeingeCommerce

Be an early applicant

$160-170k

+ Equity & Discretionary performance based annual cash bonus

Adobe Creative Suite
After Effects
Premiere Pro
Mid and Senior level
New York

2+ days a week in office

101-200 employees

B2CFoodNutritionConsumer GoodsWellbeingeCommerce

Company mission

To make the best formula in the world.

Company mission

To make the best formula in the world.

Few candidates hear
back within 2 weeks

62% employee growth in 12 months

Our take

The infant formula market in the US has long been dominated by a few major players, but recent supply chain disruptions and plant closures have opened the door for smaller companies to step in. One standout among these new players is ByHeart, which has quickly gained traction in the market. This success is largely due to ByHeart's early FDA approval, allowing the company to meet the increased demand during the formula crisis when larger competitors struggled to keep up.

ByHeart's focus on high-quality, small-batch formula made from grass-fed whole milk and all-natural ingredients has resonated with parents looking for trusted alternatives. This approach, combined with the acquisition of Cascadia Nutrition, gives ByHeart full control over its manufacturing process, ensuring the safety, quality, and reliability of its products.

Alongside this, the company recently raised significant funding to further boost its rapid growth. With this capital, ByHeart plans to expand its commercial presence in the US, and further develop its product pipeline. With such huge achievements to its name already, the company is in prime position to truly dominate the market.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Funding (last 2 of 3 rounds)

May 2024

$95m

LATE VC

Jul 2021

$90m

SERIES B

Total funding: $255m

Leadership

Ron Belldegrun

(Co-Founder & CEO)

Currently an Executive Board Member at Clean Label Project and a Steering Committee Member at the International Milk Genomics Consortium. They are also the Founder and Managing Partner at Consumer Health Ventures.

Jobs (4)

All locations

Marketing